-
Althaus C F, Vongrad V, Niederost B. Tailored enrichment strategy detects low abundant small noncoding RNAs in HIV-1 infected cells[J]. Retrovirology, 2012, 9(): 27-. doi: 10.1186/1742-4690-9-27
-
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing[J]. J R Stat Soc B, 1995, 57(): 289-300.
-
Binette J, Cohen E A. Recent advances in the understanding of HIV-1 Vpu accessory protein functions[J]. Curr Drug Targets Immune Endocr Metabol Disord, 2004, 4(): 297-307. doi: 10.2174/1568008043339695
-
Casella C R, Rapaport E L, Finkel T H. Vpu increases susceptibility of human immunodeficiency virus type 1-infected cells to fas killing[J]. J Virol, 1999, 73(): 92-100.
-
Cashin K, Roche M, Sterjovski J. Alternative coreceptor requirements for efficient[J]. J Virol, 2011, 85(): 10699-10709. doi: 10.1128/JVI.05510-11
-
Chen M Y, Maldarelli F, Karczewski M K. Human immunodeficiency virus type 1 Vpu protein induces degradation of CD 4 in vitro: the cytoplasmic domain of CD4 contributes to Vpu sensitivity[J]. J Virol, 1993, 67(): 3877-3884.
-
Cohen E A, Terwilliger E F, Sodroski J G. Identification of a protein encoded by the vpu gene of HIV-1[J]. Nature, 1988, 334(): 532-534. doi: 10.1038/334532a0
-
D'Agostino D M, Felber B K, Harrison J E. The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs[J]. Mol Cell Biol, 1992, 12(): 1375-1386. doi: 10.1128/MCB.12.3.1375
-
de Jong J J, de Ronde A, Keulen W. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution[J]. J Virol, 1992, 66(): 6777-6780.
-
Dejucq N, Simmons G, Clapham P R. T-cell line adaptation of human immunodeficiency virus type 1 strain SF162: effects on envelope, vpu and macrophage-tropism[J]. J Gen Virol, 2000, 81(): 2899-2904. doi: 10.1099/0022-1317-81-12-2899
-
Dimonte S, Mercurio F, Svicher V. Selected amino acid mutations in HIV-1 B subtype gp41 are associated with specific gp120V3 signatures in the regulation of co-receptor usage[J]. Retrovirology, 2011, 8(): 33-. doi: 10.1186/1742-4690-8-33
-
Dimonte S, Mercurio F, Svicher V. Genetic and Structural Analysis of HIV-1 Rev Responsive Element Related to V 38A and T 18A Enfuvirtide Resistance Mutations[J]. Intervirology, 2012, 55(): 385-390. doi: 10.1159/000334696
-
Dimonte S, Svicher V, Salpini R. HIV -2 A -subtype gp 125C 2-V3-C3 mutations and their association with CCR5 and CXCR4 tropism[J]. Arch Virol, 2011, 156(): 1943-1951. doi: 10.1007/s00705-011-1075-z
-
Dube M, Bego M G, Paquay C. Modulation of HIV-1-host interaction: role of the Vpu accessory protein[J]. Retrovirology, 2010, 7(): 114-. doi: 10.1186/1742-4690-7-114
-
Fouchier R A, Groenink M, Kootstra N A. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule[J]. J Virol, 1992, 66(): 3183-3187.
-
Fujita K, Omura S, Silver J. Rapid degradation of CD 4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors[J]. J Gen Virol, 1997, 78(Pt 3): 619-625.
-
Ghaffari G, Tuttle D L, Briggs D. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages[J]. J Virol, 2005, 79(): 13250-13261. doi: 10.1128/JVI.79.21.13250-13261.2005
-
Gottlinger H G, Dorfman T, Cohen E A. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses[J]. Proc Natl Acad Sci U S A, 1993, 90(): 7381-7385. doi: 10.1073/pnas.90.15.7381
-
Hout D R, Gomez L M, Pacyniak E. A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine[J]. Virology, 2006, 348(): 449-461. doi: 10.1016/j.virol.2005.12.025
-
Huang C C, Lam S N, Acharya P. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4[J]. Science, 2007, 317(): 1930-1934. doi: 10.1126/science.1145373
-
Hussain A, Das S R, Tanwar C. Oligomerization of the human immunodeficiency virus type 1 (HIV-1) Vpu protein -a genetic, biochemical and biophysical analysis[J]. Virol J, 2007, 4(): 81-. doi: 10.1186/1743-422X-4-81
-
Iwatani Y, Song S K, Wang L. Human immunodeficiency virus type 1 Vpu modifies viral cytopathic effect through augmented virus release[J]. J Gen Virol, 1997, 78(Pt 4): 841-846.
-
Jiang C, Parrish N F, Wilen C B. Primary infection by a human immunodeficiency virus with atypical coreceptor tropism[J]. J Virol, 2011, 85(): 10669-10681. doi: 10.1128/JVI.05249-11
-
Karn J, Stoltzfus C M. Transcriptional and Posttranscriptional Regulation of HIV-1 Gene Expression[J]. Cold Spring Harb Perspect Med, 2012, 2(): a006916-.
-
Kawamura M, Ishizaki T, Ishimoto A. Growth ability of human immunodeficiency virus type 1 auxiliary gene mutants in primary blood macrophage cultures[J]. J Gen Virol, 1994, 75(Pt 9): 2427-2431.
-
Krummheuer J, Johnson A T, Hauber I. A minimal uORF within the HIV-1 vpu leader allows efficient translation initiation at the downstream env AUG[J]. Virology, 2007, 363(): 261-271. doi: 10.1016/j.virol.2007.01.022
-
Magadan J G, Bonifacino J S. Transmembrane domain determinants of CD4 Downregulation by HIV-1 Vpu[J]. J Virol, 2012, 86(): 757-772. doi: 10.1128/JVI.05933-11
-
Marchal C, Vinatier G, Sanial M. The HIV-1 Vpu Protein Induces Apoptosis in Drosophila via Activation of JNK Signaling[J]. PLoS One, 2012, 7(): e34310-. doi: 10.1371/journal.pone.0034310
-
Margottin F, Benichou S, Durand H. Interaction between the cytoplasmic domains of HIV-1 Vpu and CD4: role of Vpu residues involved in CD4 interaction and in vitro CD4 degradation[J]. Virology, 1996, 223(): 381-386. doi: 10.1006/viro.1996.0491
-
Michalski C J, Li Y, Kang C Y. Induction of cytopathic effects and apoptosis in Spodoptera frugiperda cells by the HIV-1 Env glycoprotein signal peptide[J]. Virus Genes, 2010, 41(): 341-350. doi: 10.1007/s11262-010-0527-y
-
Park S H, Opella S J. Conformational changes induced by a single amino acid substitution in the trans-membrane domain of Vpu: implications for HIV-1 susceptibility to channel blocking drugs[J]. Protein Sci, 2007, 16(): 2205-2215. doi: 10.1110/(ISSN)1469-896X
-
Peterlin B M, Trono D. Hide, shield and strike back: how HIV-infected cells avoid immune eradication[J]. Nat Rev Immunol, 2003, 3(): 97-107. doi: 10.1038/nri998
-
Richards K H, Clapham P R. Effects of vpu start-codon mutations on human immunodeficiency virus type 1 replication in macrophages[J]. J Gen Virol, 2007, 88(): 2780-2792. doi: 10.1099/vir.0.83120-0
-
Schubert U, Clouse K A, Strebel K. Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes[J]. J Virol, 1995, 69(): 7699-7711.
-
Schubert U, Henklein P, Boldyreff B. The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif[J]. J Mol Biol, 1994, 236(): 16-25. doi: 10.1006/jmbi.1994.1114
-
Schwartz S, Felber B K, Pavlakis G N. Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs[J]. Mol Cell Biol, 1992, 12(): 207-219. doi: 10.1128/MCB.12.1.207
-
Shibata R, Hoggan M D, Broscius C. Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo[J]. J Virol, 1995, 69(): 4453-4462.
-
Stephens E B, McCormick C, Pacyniak E. Deletion of the vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques[J]. Virology, 2002, 293(): 252-261. doi: 10.1006/viro.2001.1244
-
Strebel K, Klimkait T, Martin M A. A novel gene of HIV-1, vpu, and its 16-kilodalton product[J]. Science, 1988, 241(): 1221-1223. doi: 10.1126/science.3261888
-
Svicher V, Alteri C, D'Arrigo R. Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev[J]. Antimicrob Agents Chemother, 2009, 53(): 2816-2823. doi: 10.1128/AAC.01067-08
-
Svicher V, Cammarota R, Artese A, et al. 2010. New V3-genetic Signatures Modulate Co-receptor Usage in vivo and the Interaction with CCR5 N-terminus. [paper 542]. In: Program and abstracts of the 17th Conference on Retroviruses and Opportunistic Infections; February 16-19, 2010; San Francisco, CA (http://retroconference.org/2010/Abstracts/38958.htm)
-
Taylor W R. The classification of amino acid conservation[J]. J Theor Biol, 1986, 119(): 205-218. doi: 10.1016/S0022-5193(86)80075-3
-
Verma S, Ali A, Arora S. Inhibition of beta-TrcP-dependent ubiquitination of p53 by HIV-1 Vpu promotes p53-mediated apoptosis in human T cells[J]. Blood, 2011, 117(): 6600-6607. doi: 10.1182/blood-2011-01-333427
-
Waheed A A, Freed E O. The Role of Lipids in Retrovirus Replication[J]. Viruses, 2010, 2(): 1146-1180. doi: 10.3390/v2051146
-
Wilen C B, Tilton J C, Doms R W. Molecular mechanisms of HIV entry[J]. Adv Exp Med Biol, 2012, 726(): 223-242. doi: 10.1007/978-1-4614-0980-9